Royalty Pharma plc (MUN:RPD)
Germany · Delayed Price · Currency is EUR 33.50
-0.56 (-1.64%)
At close: Jan 2, 2026
Royalty Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 764.96 | 858.98 | 1,135 | 42.83 | 619.73 | 975.04 |
Depreciation & Amortization | 2.66 | - | - | 5.67 | 23 | 23.06 |
Other Amortization | 22.03 | 19.56 | 20.5 | 21.36 | 20.16 | 11.72 |
Asset Writedown & Restructuring Costs | - | - | - | 615.83 | - | 65.05 |
Loss (Gain) From Sale of Investments | 26.69 | -194.46 | -317.98 | 40.26 | 30.21 | -265.67 |
Loss (Gain) on Equity Investments | -43.34 | -16.22 | -10.06 | 48.12 | 53.87 | -2.13 |
Stock-Based Compensation | 164.65 | 2.34 | 2.36 | 2.17 | 2.44 | 5.43 |
Provision & Write-off of Bad Debts | -154.91 | 732.46 | 560.66 | 904.24 | 452.84 | 230.84 |
Other Operating Activities | -1,579 | -1,670 | -1,609 | -2,076 | -1,484 | -1,207 |
Change in Accounts Receivable | 3,216 | 2,983 | 3,201 | 2,507 | 2,296 | 2,122 |
Change in Accounts Payable | 8.73 | -2.29 | 6.24 | 2.29 | -4.59 | -0.77 |
Change in Other Net Operating Assets | -22.87 | 55.67 | -0.85 | 30.38 | 8.4 | 76.36 |
Operating Cash Flow | 2,405 | 2,769 | 2,988 | 2,144 | 2,018 | 2,035 |
Operating Cash Flow Growth | -14.07% | -7.32% | 39.36% | 6.27% | -0.84% | 22.04% |
Sale (Purchase) of Intangibles | -1,460 | -2,506 | -2,116 | -1,742 | -2,192 | -2,182 |
Investment in Securities | 547.46 | -99.45 | 57.17 | 712.22 | 339.82 | -577.07 |
Other Investing Activities | -284.55 | -72.96 | -14.44 | - | -18.6 | - |
Investing Cash Flow | -1,272 | -2,678 | -2,073 | -1,029 | -1,870 | -2,759 |
Short-Term Debt Issued | - | - | 350 | - | - | - |
Long-Term Debt Issued | - | 1,471 | - | - | 1,273 | 11,891 |
Total Debt Issued | 3,229 | 1,471 | 350 | - | 1,273 | 11,891 |
Short-Term Debt Repaid | - | - | -350 | - | - | - |
Long-Term Debt Repaid | - | - | -1,000 | - | - | -11,210 |
Total Debt Repaid | -2,275 | - | -1,350 | - | - | -11,210 |
Net Debt Issued (Repaid) | 954.48 | 1,471 | -1,000 | - | 1,273 | 680.63 |
Issuance of Common Stock | - | - | - | - | - | 1,150 |
Repurchase of Common Stock | -1,199 | -229.65 | -304.76 | - | - | - |
Common Dividends Paid | -377.57 | -376.47 | -358.33 | -333.32 | -285.18 | -397.84 |
Other Financing Activities | -521.8 | -503.97 | -485.67 | -611.53 | -602.24 | 53.99 |
Financing Cash Flow | -1,144 | 361.15 | -2,149 | -944.86 | 385.11 | 1,487 |
Net Cash Flow | -11.11 | 452.02 | -1,234 | 169.7 | 532.37 | 762.48 |
Cash Interest Paid | 270.42 | 159.57 | 169.17 | 170.14 | 130.43 | 103.2 |
Levered Free Cash Flow | -590.95 | -1,759 | -1,245 | -1,384 | -1,547 | -1,087 |
Unlevered Free Cash Flow | -438.45 | -1,637 | -1,149 | -1,288 | -1,463 | -993.85 |
Change in Working Capital | 3,202 | 3,037 | 3,207 | 2,540 | 2,300 | 2,198 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.